Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials.
G. Bryson underlines the importance of exercizing caution when interpreting the results of such a systematic review. He maintains that the absence of statistical risk is not conducive to albumin’s safety.
P. Choi echoes G. Bryson’s concerns of interpretation and concludes that further research is necessary in order to make any claims concerning albumin’s safety.
Further commentaries of this article by Deborah J. Cook, MD, MSc and Gordon H. Guyatt, MD, MSc from McMaster University can be found here.